Your browser doesn't support javascript.
loading
Exosomes derived from human adipose mesenchymal stem cells ameliorate hepatic fibrosis by inhibiting PI3K/Akt/mTOR pathway and remodeling choline metabolism.
Zhang, Zilong; Shang, Jin; Yang, Qinyan; Dai, Zonglin; Liang, Yuxin; Lai, Chunyou; Feng, Tianhang; Zhong, Deyuan; Zou, Haibo; Sun, Lelin; Su, Yuhao; Yan, Su; Chen, Jie; Yao, Yutong; Shi, Ying; Huang, Xiaolun.
Afiliação
  • Zhang Z; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Shang J; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Yang Q; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Dai Z; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Liang Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Lai C; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Feng T; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Zhong D; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Zou H; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Sun L; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Su Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Yan S; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Chen J; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Yao Y; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
  • Shi Y; Liver Transplantation Center and HBP Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, Cancer Hospital Affiliate to University of Electronic Science and Technology of China, Chengdu, 610042, Sichuan, China.
  • Huang X; School of Medicine, University of Electronic Science and Technology of China, Chengdu, 610054, Sichuan, China.
J Nanobiotechnology ; 21(1): 29, 2023 Jan 25.
Article em En | MEDLINE | ID: mdl-36698192

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exossomos / Células-Tronco Mesenquimais Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Exossomos / Células-Tronco Mesenquimais Limite: Animals / Humans Idioma: En Revista: J Nanobiotechnology Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China País de publicação: Reino Unido